| Automated cassette-based production of high specific activity [203/212Pb] peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer M Li, X Zhang, TP Quinn, D Lee, D Liu, F Kunkel, BE Zimmerman, ... Applied Radiation and Isotopes 127, 52-60, 2017 | 46 | 2017 |
| Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper KC Falls-Hubert, AL Butler, K Gui, M Anderson, M Li, JM Stolwijk, ... Free Radical Biology and Medicine 150, 1-11, 2020 | 34 | 2020 |
| High content screening identifies monensin as an EMT-selective cytotoxic compound M Vanneste, Q Huang, M Li, D Moose, L Zhao, MA Stamnes, M Schultz, ... Scientific reports 9 (1), 1200, 2019 | 34 | 2019 |
| 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer M Li, EE Sagastume, D Lee, D McAlister, AJ DeGraffenreid, KR Olewine, ... Current Medicinal Chemistry 27 (41), 7003-7031, 2020 | 30 | 2020 |
| Enhancing the efficacy of melanocortin 1 receptor-targeted radiotherapy by pharmacologically upregulating the receptor in metastatic melanoma M Li, D Liu, D Lee, S Kapoor, KN Gibson-Corley, TP Quinn, ... Molecular pharmaceutics 16 (9), 3904-3915, 2019 | 27 | 2019 |
| Modeling cell and tumor-metastasis dosimetry with the particle and heavy ion transport code system (PHITS) software for targeted alpha-particle radionuclide therapy D Lee, M Li, B Bednarz, MK Schultz Radiation research 190 (3), 236-247, 2018 | 27 | 2018 |
| Targeted alpha-particle radiotherapy and immune checkpoint inhibitors induces cooperative inhibition on tumor growth of malignant melanoma M Li, D Liu, D Lee, Y Cheng, NJ Baumhover, BM Marks, EA Sagastume, ... Cancers 13 (15), 3676, 2021 | 24 | 2021 |
| Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics M Li, NJ Baumhover, D Liu, BS Cagle, F Boschetti, G Paulin, D Lee, Z Dai, ... Pharmaceutics 15 (2), 414, 2023 | 13 | 2023 |
| 212Pb-pretargeted theranostics for pancreatic cancer D Bauer, LM Carter, MI Atmane, R De Gregorio, A Michel, S Kaminsky, ... Journal of Nuclear Medicine 65 (1), 109-116, 2024 | 7 | 2024 |
| Synthesis and evaluation of diaza-crown ether-backboned chelator containing hydroxamate groups for Zr-89 chelation chemistry S Zhang, H Wang, S Ren, Y Chen, D Liu, M Li, E Sagastume, HS Chong Bioorganic & medicinal chemistry letters 72, 128847, 2022 | 6 | 2022 |
| Compositions and methods of treating melanoma MK Schultz, FL Johnson, S Kapoor, D Lee, M Li, M Martin US Patent 11,179,484, 2021 | 5 | 2021 |
| Optimizing the radiosynthesis of [68Ga] DOTA-MLN6907 peptide containing three disulfide cyclization bonds–a GCC specific chelate for clinical radiopharmaceuticals A Ghai, B Singh, M Li, TA Daniels, R Coelho, K Orcutt, GL Watkins, ... Applied Radiation and Isotopes 140, 333-341, 2018 | 5 | 2018 |
| Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors D Lee, M Li, D Liu, NJ Baumhover, EA Sagastume, BM Marks, P Rastogi, ... European journal of nuclear medicine and molecular imaging 51 (4), 1147-1162, 2024 | 3 | 2024 |
| Targeting the BB2 receptor in prostate cancer using a Pb-203 labeled peptide. N Okoye, T Rold, A Berendzen, X Zhang, R White, M Schultz, M Li, ... Journal of Nuclear Medicine 58 (supplement 1), 321-321, 2017 | 3 | 2017 |
| Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy M Li, C Robles-Planells, D Liu, SA Graves, G Vasquez-Martinez, ... European journal of nuclear medicine and molecular imaging 51 (5), 1395-1408, 2024 | 2 | 2024 |
| Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses KD Orcutt, KE Henry, C Habjan, K Palmer, J Heimann, JM Cupido, ... Molecules 27 (18), 5831, 2022 | 2 | 2022 |
| Radiobiology of Targeted Alpha Therapy MK Schultz, JP Pouget, F Wuest, B Nelson, J Andersson, S Cheal, M Li, ... Nuclear Medicine and Molecular Imaging: Volume 1-4, 380-403, 2022 | 2 | 2022 |
| Preclinical evaluation of 203/212Pb-based theranostics-dosimetry and renal toxicity. M Li, E Sagastume, D Zepeda-Orozco, H Wen, S Graves, D Lee, D Liu, ... Journal of Nuclear Medicine 61 (supplement 1), 289-289, 2020 | 2 | 2020 |
| MAPK-pathway inhibition driven changes in cellular thiol-redox state mediate drug resistance in metastatic melanoma S Kapoor, M Li, D Lee, E Sagastume, F Johnson, M Schultz Pigment Cell & Melanoma Research 33 (1), 191-191, 2020 | 2 | 2020 |
| Compositions and methods of treating melanoma MK Schultz, FL Johnson, S Kapoor, D Lee, M Li, M Martin US Patent 11,576,987, 2023 | 1 | 2023 |
Dongyoul LeeKorea Military Academy在 uiowa.edu 的电子邮件经过验证
Dongyoul LeeKorea Military Academy在 uiowa.edu 的电子邮件经过验证